J Pathol 2004,204(1):101–109.PubMedCrossRef MLN2238 18. Szoke T, Kayser K, Trojan I, Kayser G, Furak J, Tiszlavicz L, Baumhakel JD, Gabius HJ: The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II. Eur J Cardiothorac Surg 2007,31(5):783–787.PubMedCrossRef 19. Puglisi F, Minisini AM, Barbone F, Intersimone D, Aprile G, Puppin C, Damante G, Paron I, Tell G, Piga A, Di Loreto C: Galectin-3 expression in non-small cell lung carcinoma. Cancer Lett 2004,212(2):233–239.PubMedCrossRef 20. Mathieu A, Saal

I, Vuckovic A, Ransy V, Vereerstraten P, Kaltner H, Gabius HJ, Kiss R, Decaestecker C, Salmon I, Remmelink M: Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol 2005,18(9):1264–1271.PubMedCrossRef Selleck GANT61 21. Hubert M, Wang SY, Wang JL, Seve AP, Hubert J: Intracellular distribution of galectin-3 in mouse 3T3 fibroblasts: comparative analyses by immunofluorescence and immunoelectron microscopy. Exp Cell Res 1995,220(2):397–406.PubMedCrossRef 22. Wu MH, Hong TM, Cheng HW, Pan SH, Liang YR, Hong HC, Chiang WF, Wong TY, Shieh DB, Shieh AL, Jin YT, Chen YL: Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase

expression, and reorganized actin cytoskeletons. Mol Cancer Res 2009,7(3):311–318.PubMedCrossRef 23. Wu ZH, Gan L: Association of galectin-3 and E-cadherin expression with node metastasis of colon cancer. Nan Fang Yi Ke Da Xue Xue Bao 2007,27(11):1731–1733.PubMed 24. Liang Y, Li H, Hou SC, Hu B, Miao JB, Li T, You B, Yu LX, Wang L, Chen QR, Chen X: The expression of galectin-3 and osteopontin in occult metastasis of non-small cell lung cancer. Zhonghua Wai P-type ATPase Ke Za Zhi 2009,47(14):1061–1063.PubMed 25. Mishina T, Dosaka-Akita H, Kinoshita I, Hommura F, Morikawa T, Katoh H, Kawasaki Y: Cyclin

D1 expression in non -small-cell lung cancer: its association with altered p53 expression, cell proliferation and clinical outcome. Br J Cancer 1999,80(8):1289–1295.PubMedCrossRef 26. Ayeda AK, Adesina A: Prognostic significance of cyclin D1 expression in resected stage I, II non-small cell lung cancer in Arabs. Interact CardioVasc Thorac Surg 2006, 5:47–51.CrossRef 27. Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, AZD5153 solubility dmso Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T: Prognostic implications of cell cycle-related proteins in primary resectable N2 non-small cell lung cancer. Cancer 2007,109(12):2506–2514.PubMedCrossRef 28. Ferrazzo KL, Neto MM, dos Santos E, dos Santos Pinto D, de Sousa SO: Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphus low-grade adenocarcinoma of salivary glands. J Oral Pathol Med 2009,38(9):701–707.PubMedCrossRef 29.